Gujarat Terce Laboratories share news and announcements
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Last close ₹34.13down ₹2.78 (7.53%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹36.91.
52-week range of traded prices to 23 Oct 2026
₹29.00Low, 30 Mar 2026₹53.49High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹27 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 12.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 2.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,356
Gujarat Terce Laboratories share news and announcements
523 announcements, routine notices left out, newest first. Page 11 of 11.
Apr 2011
13 Apr · Board meeting
Board of Directors of the Company at its Meeting held on March 12, 2011, has recommended the members to pass a special resolution ....4 Apr · Board Meeting on Apr 12, 2011
Meeting of the Board of Directors of the Company will be held on April 12, 2011, inter alia, to consider and appoint Shri Paresh Patel ....
Feb 2011
Jan 2011
20 Jan · Conversion of Equity Warrants into equity shares
On January 19, 2011 the Board of Directors has converted 25,00,000 equity warrants into 25,00,000 equity shares at a price of Rs. 16/- ....
Oct 2010
29 Oct · Results
Financial Results for the Quarter ended September 30, 2010.
Aug 2010
3 Aug · Meeting
Annual General Meeting (AGM) of the Company is scheduled to be held on August 13, 2010.
Jul 2010
27 Jul · Board meeting
Board of Directors of the Company in the meeting held on June 29, 2010, has decided to create, offer and allot up to 25,00,000 Equity ....6 Jul · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 30, 2010 to August 06, 2010 (both days inclusive) ....
Jun 2010
30 Jun · Corporate action
With reference to earlier announcement dated June 29, 2010 regarding outcome of Board Meeting & Rights Issue, Gujarat Terce Laboratories Ltd has now informed BSE that the Company had stated ....29 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 29, 2010, has taken following decisions: 1. To issue 32,80,200 ....23 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 22, 2010, inter alia, has taken the following decisions: 1. ....17 Jun · Board Meeting on Jun 22, 2010
Meeting of the Board of Directors of the Company will be held on June 22, 2010, inter alia, to consider a proposal to diversify into ....
May 2010
Mar 2010
Feb 2010